Sign In |Help & Support
ALL SECTORS
  • ALL SECTORS
  • GB(National Standard)
  • CB(Shipping)
  • CECS(Engineering Construction)
  • CJ(Urban Construction)
  • CY(News and Publication)
  • DB(Provincial Standard)
  • DL(Electricity & Power)
  • DZ(Geology & Mineralogy)
  • FZ(Spinning & Textile)
  • GA(Public Security)
  • HB(Aviation)
  • HG(Chemical Industry)
  • HJ(Environmental Protection)
  • JB(Machinery)
  • JC(Building Materials)
  • JG(Building & Construction)
  • JJ(Metering)
  • JT(Highway & Transportation)
  • LY(Forestry)
  • MT(Coal)
  • NB(Energy)
  • NY(Agriculture)
  • QB(Light Industry)
  • QC(Automobile & Vehicle)
  • QJ(Aerospace)
  • SH(Petrochemical)
  • SJ(Electronics)
  • SL(Water Resources)
  • SN(Commodity Inspection)
  • SY(Oil & Gas)
  • TB(Railway & Train)
  • YB(Ferrous Metallurgy)
  • YC(Tobacco)
  • YD(Telecommunication)
  • YY(Medical Device)
Database: 365,228(8 Aug 2026)

Phase separation experiments in living cells

Phase separation experiments in living cells, Total:103 items.

The international standard classification for "Phase separation experiments in living cells" includes: Water of natural resources , Protection against dangerous goods , Pesticides and other agrochemicals , Internal combustion engines .

The Chinese standard classification for "Phase separation experiments in living cells" includes: Specifications for pollution control , Marking, packaging, transport and storage in general , Medical apparatus and devices in general , Engine body and moving parts , Pesticide management and application method .


Group Standards of the People's Republic of China

  • T/CSBM 0044-2023 Non-antibody-dependent magnetic separation detection method of circulating tumor cells in peripheral blood
  • T/SPEMF 0050-2023 Technical standards for selection of ligand-free on living cells
  • T/CMBA 011-2020 Collection, Separation and Preservation of PBMC from Human Peripheral Blood
  • T/YZXMR 001-2021 Isolation and culture method of dental pulp stem cells
  • T/CRHA 013-2022 Specification for menstrual blood-derived mesenchymal stem cells resource storage - Part 2:Isolation, processing and cryopreservation of menstrual blood-derived mesenchymal stem cells
  • T/SZLSBA 02-2023 Technical standards for selection of ligand-free on living cells
  • T/CSUS 31-2021 Water quality―Determination of the estrogenic potential of water and wastewater―In vitro human cell-based reporter gene assay
  • T/CRHA 007-2022 Specification for mononuclear cell resource storage in healthy blood donors Part 4:Isolation, processing and cryopreservation of mononuclear cells
  • T/SHRH 027-2019 In Vitro Test -Inhibition of Melanin Synthesis in B16 Cells Test

Professional Standard - Commodity Inspection

  • SN/T 2497.23-2010 Test method of import and export dangerous chemicals—Part 23:Separation of cellular organelles

General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China

  • GB/T 15670.17-2017 Toxicological test methods for pesticides registration. Part 17: Mammalian spermatogonial/spermatocyte chromosome aberration test
  • GB 2805-1981 Metallographic inspection for individually cast piston ring of reciprocating internal combustion engine
  • GB/T 21767-2008 Chemical - Test method of unscheduled DNA synthesis (UDS) test with mammalian liver cells In Vivo
  • GB/T 15670.16-2017 Toxicological test methods for pesticides registration. Part 16: In vivo mammalian bone marrow cell chromosome aberration test
  • GB/T 43279.1-2023 Molecular in vitro diagnostic examinations—Specifications for pre-examination processes for venous whole blood—Part 1: Isolated cellular RNA
  • GB/T 43450-2023 Chemicals—In vitro cellular assay for acute eye irritation—TRPV1 activity detection method
  • GB/T 21773-2008 Chemicals - Test method of in vivo mammalian erythrocyte micronucleus

未注明发布机构

  • DIN ISO 13022 E:2013-07 Medical products containing viable human cells - Application of risk management and requirements for processing practices

国家食品药品监督管理局

  • YY/T 1465.4-2017 Immunogenic evaluation method of medical devices-Part4:Phagocytosis of mouse peritoneal macrophages on chicken erythrocytes- Ex-vivo method

Professional Standard - Machinery

  • JB/T 6016.1-2008 Internal combustion engines-Piston rings-Metallographic inspections-Part1:For singlecast cast iron
  • JB/T 6016-1992 Metallographic Examination of Single Cast Piston Ring of Internal Combustion Engine
  • JB/T 6290-1992 Metallographic Examination of Internal Combustion Engine Cylinder Casting Piston Ring
  • JB/T 6016.5-2011 Internal combustion engines — Piston rings — Metallographic inspections —Part 5:For boracic cast iron piston rings by individual cast
  • JB/T 6290-2007 Internal combustion engines-Sleeve cast piston rings-Metallographic inspections

Taiwan Provincial Standard of the People's Republic of China

  • CNS 14393.5-2004 Biological evaluation of medical devices – Part 5:Tests for in vitro cytotoxicity

American Society for Testing and Materials (ASTM)

  • ASTM E1398-91(2003) Standard Practice for the in vivo Rat Hepatocyte DNA Repair Assay
  • ASTM F2739-19 Standard Guide for Quantifying Cell Viability and Related Attributes within Biomaterial Scaffolds
  • ASTM F2739-16 Standard Guide for Quantifying Cell Viability within Biomaterial Scaffolds
  • ASTM E1398-91(2008) Standard Practice for In Vivo Rat Hepatocyte DNA Repair Assay
  • ASTM E1398-91(1998) Standard Practice for the in vivo Rat Hepatocyte DNA Repair Assay
  • ASTM F1903-18 Standard Practice for Testing for Cellular Responses to Particles in vitro
  • ASTM F2739-08 Standard Guide for Quantitating Cell Viability Within Biomaterial Scaffolds
  • ASTM F1906-98 Standard Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte, Proliferation, and Cell Migration
  • ASTM E1397-91(2008) Standard Practice for In Vitro Rat Hepatocyte DNA Repair Assay
  • ASTM E1397-91(1998) Standard Practice for the in vitro Rat Hepatocyte DNA Repair Assay
  • ASTM E1397-91(2003) Standard Practice for the in vitro Rat Hepatocyte DNA Repair Assay
  • ASTM F3106-22 Standard Guide for in vitro Osteoblast Differentiation Assays
  • ASTM F34-13(2018) Standard Practice for Construction of Test Cell for Liquid Extraction of Flexible Barrier Materials
  • ASTM F1027-86(2012) Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices
  • ASTM F3088-14 Standard Test Method for Use of a Centrifugation Method to Quantify/Study Cell-Material Adhesive Interactions
  • ASTM E1263-97(2003) Standard Guide for Conduct of Micronucleus Assays in Mammalian Bone Marrow Erythrocytes
  • ASTM E1263-97 Standard Guide for Conduct of Micronucleus Assays in Mammalian Bone Marrow Erythrocytes
  • ASTM F2131-02 Standard Test Method for In Vitro Biological Activity of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) Using the W-20 Mouse Stromal Cell Line
  • ASTM F2131-02(2007)e1 Standard Test Method for In Vitro Biological Activity of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) Using the W-20 Mouse Stromal Cell Line
  • ASTM F2149-01(2007) Standard Test Method for Automated Analyses of Cells-the Electrical Sensing Zone Method of Enumerating and Sizing Single Cell Suspensions
  • ASTM F2149-01 Standard Test Method for Automated Analyses of Cells8212;the Electrical Sensing Zone Method of Enumerating and Sizing Single Cell Suspensions
  • ASTM F3106-14 Standard Guide for in vitro Osteoblast Differentiation Assays

KR-KS

  • KS M ISO 4590-2018 Rigid cellular plastics — Determination of the volume percentage of open cells and of closed cells
  • KS P ISO 13022-2018(2023) Medical products containing viable human cells — Application of risk management and requirements for processing practices

HU-MSZT

Korean Agency for Technology and Standards (KATS)

  • KS M ISO 4590:2018 Rigid cellular plastics — Determination of the volume percentage of open cells and of closed cells
  • KS P ISO 13022-2023 Medical products containing viable human cells — Application of risk management and requirements for processing practices

SCC

  • AWWA JAW30405 Journal AWWA — Inactivation of Cell-Associated and Dispersed Hepatitis A Virus in Water
  • AAMI/ISO 13022:2012 Medical products containing viable human cells -- Application of risk management and requirements for processing practices
  • DANSK DS/ISO 13022:2012 Medical products containing viable human cells - Application of risk management and requirements for processing practices
  • BS PD CEN/TS 17688-1:2021 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for Fine Needle Aspirates (FNAs)-Isolated cellular RNA
  • CSA ISO 20186-1:2022 Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 1: Isolated cellular RNA
  • 10/30203224 DC BS ISO 13022. Medical products containing viable human cells. Application of risk management and requirements for processing practices
  • SN-CEN/TS 17688-1:2021 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for Fine Needle Aspirates (FNAs) - Part 1: Isolated cellular RNA
  • DIN CEN/TS 17688-1:2022 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for Fine Needle Aspirates (FNAs) - Part 1: Isolated cellular RNA; German version CEN/TS 17688-1:2021
  • DIN ISO 13022 E:2013 Draft Document - Medical products containing viable human cells - Application of risk management and requirements for processing practices (ISO 13022:2012)
  • DIN EN ISO 20186-3 E:2018 Draft Document - Molecular in-vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood - Cellular RNA - Part 3: Isolated circulating cell free DNA from plasma (ISO/DIS 20186-3:2018); German and English version...
  • DANSK DS/CEN/TS 17688-1:2022 Molecular in vitro diagnostic examinations – Specifications for pre-examination processes for Fine Needle Aspirates (FNAs) – Part 1: Isolated cellular RNA
  • CAN/CSA-ISO 20186-3-2022 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood - Part 3: Isolated circulating cell free DNA from plasma
  • BS PD CEN/TS 16835-1:2015 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for venous whole blood-Isolated cellular RNA
  • DANSK DS/CEN/TS 17811:2022 Molecular in vitro diagnostic examinations – Specifications for pre-examination processes for urine and other body fluids – Isolated cell free DNA
  • SN-CEN/TS 17811:2022 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for urine and other body fluids - Isolated cell free DNA
  • BS PD CEN/TS 17811:2022 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for urine and other body fluids. Isolated cell free DNA
  • BS PD CEN/TS 17742:2022 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for venous whole blood. Isolated circulating cell free RNA from plasma
  • DIN CEN/TS 17742:2022 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood - Isolated circulating cell free RNA from plasma; German version CEN/TS 17742:2022
  • AWWA PATH56522 Applications of In-Vitro Cell Culture for Measuring Infectivity and Inactivation of Cryptosporidium parvum
  • DANSK DS/CEN/TS 17742:2022 Molecular in vitro diagnostic examinations – Specifications for pre-examination processes for venous whole blood – Isolated circulating cell free RNA from plasma

US-AAMI

  • ANSI/AAMI/ISO 13022:2012 Medical products containing viable human cells.Application of risk management and requirements for processing practices

API - American Petroleum Institute

International Organization for Standardization (ISO)

  • ISO 13022:2012 Medical products containing viable human cells - Application of risk management and requirements for processing practices
  • ISO 20186-3:2019 Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 3: Isolated circulating cell free DNA from plasma

British Standards Institution (BSI)

  • PD CEN/TS 17688-1:2021 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for Fine Needle Aspirates (FNAs). Isolated cellular RNA
  • PD CEN/TS 17811:2022 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for urine and other body fluids. Isolated cell free DNA
  • BS EN ISO 10993-5:1999 Biological evaluation of medical devices - Tests for in vitro cytotoxicity
  • BS EN ISO 20186-1:2019 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for venous whole blood - Isolated cellular RNA

German Institute for Standardization

  • DIN ISO 13022:2014-06 Medical products containing viable human cells - Application of risk management and requirements for processing practices (ISO 13022:2012)
  • DIN 58933-1:1995-01 Haematology - Procedure for determining the volume fraction of erythrocytes (packed cell volume) in blood - Part 1: Reference method based on centrifugation
  • DIN ISO 13022:2014 Medical products containing viable human cells - Application of risk management and requirements for processing practices (ISO 13022:2012)
  • DIN CEN/TS 17688-1:2022-06 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for Fine Needle Aspirates (FNAs) - Part 1: Isolated cellular RNA; German version CEN/TS 17688-1:2021
  • DIN CEN/TS 17811:2022-08 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for urine and other body fluids - Isolated cell free DNA; German version CEN/TS 17811:2022

GSO

  • GSO ISO 13022:2016 Medical products containing viable human cells -- Application of risk management and requirements for processing practices
  • OS GSO ISO 13022:2016 Medical products containing viable human cells -- Application of risk management and requirements for processing practices
  • GSO ISO 20186-1:2024 Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 1: Isolated cellular RNA

RU-GOST R

  • GOST R ISO 13022-2016 Medical products containing viable human cells. Application of risk management and requirements for processing practices

European Committee for Standardization (CEN)

  • EN ISO 20186-3:2019 Molecular in-vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood - Part 3: Isolated circulating cell free DNA from plasma (ISO 20186-3:2019)
  • FprCEN/TS 17688-1-2021 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for Fine Needle Aspirates (FNAs) - Part 1: Isolated cellular RNA
  • CEN/TS 17688-1:2021 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for Fine Needle Aspirates (FNAs) - Part 1: Isolated cellular RNA
  • CEN/TS 17811:2022 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for urine and other body fluids - Isolated cell free DNA
  • prEN ISO 18704 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for urine and other body fluids - Isolated cell free DNA
  • EN ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009)

ES-UNE

  • UNE-CEN/TS 17688-1:2021 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for Fine Needle Aspirates (FNAs) - Part 1: Isolated cellular RNA (Endorsed by Asociación Española de Normalización in February of 2022.)

AT-ON

  • ONR CEN/TS 17688-1-2021 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for Fine Needle Aspirates (FNAs) - Part 1: Isolated cellular RNA

Association Francaise de Normalisation

  • NF EN ISO 29701:2011 Nanotechnologies - Endotoxin detection test on nanomaterial samples for in vitro systems - Limulus amebocyte lysate (LAL) test
  • NF S92-075-1*NF EN ISO 20186-1:2019 Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood - Part 1 : isolated cellular RNA
  • NF V04-040-1:1997 Milk. Enumeration of somatic cells. Part 1 : microscopic method.
  • NF EN ISO 17099:2018 Radioprotection - Performance criteria for laboratories carrying out biological dosimetry using the micronucleus test with blockade of cytodieresis (CBMN) in peripheral blood lymphocytes

AENOR

  • UNE 103405:1994 GEOTECHNICS. ONE-DIMENSIONAL CONSOLIDATION TEST IN AN EDOMETRIC CELL.